Sign In
Buy TECH
$56.26
+0.650 (+1.17%)
At Close: Jun 23, 2026
Bio-Techne declares $0.32 dividend and repurchase of $400M of common stock (NASDAQ:TECH)
11:44am, Tuesday, 01'st Feb 2022 Seeking Alpha
Bio-Techne (NASDAQ:TECH) declares $0.32/share quarterly dividend, in line with previous.Forward yield 0.34%Payable Feb. 25; for shareholders of record Feb. 11; ex-div Feb.
Bio-Techne Non-GAAP EPS of $1.88 beats by $0.09, revenue of $269.28M beats by $2.71M
11:35am, Tuesday, 01'st Feb 2022 Seeking Alpha
Bio-Techne press release (TECH): FQ2 Non-GAAP EPS of $1.88 beats by $0.09.Revenue of $269.28M (+20.1% Y/Y) beats by $2.71M.CEO comment: "Our teams continue to innovate and execute
Techne (TECH) Beats Q2 Earnings and Revenue Estimates
09:14am, Tuesday, 01'st Feb 2022
Techne (TECH) delivered earnings and revenue surprises of 3.30% and 0.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Bio-Techne Clocks 17% Organic Revenue Growth In Q2, Announces $400M Share Buyback
07:03am, Tuesday, 01'st Feb 2022
Bio-Techne Corporation TECH has posted Q2 FY22 sales of $269.3 million, up 20% Y/Y, beating the consensus of $266.57 million. [LIVE NOW ON YOUTUBE] Click Here to Watch a FREE MASTERCLASS on the Ult
Bio-Techne FQ2 2022 Earnings Preview
05:38pm, Monday, 31'st Jan 2022 Seeking Alpha
Bio-Techne (NASDAQ:TECH) is scheduled to announce FQ2 earnings results on Tuesday, February 1st, before market open.The consensus EPS Estimate is $1.79 (+10.5% Y/Y) and the
Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
08:00pm, Tuesday, 25'th Jan 2022 Zacks Investment Research
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04:10pm, Tuesday, 25'th Jan 2022
Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These stocks in the S&P 500 had price swings of 10% or more Monday
11:08am, Tuesday, 25'th Jan 2022 MarketWatch
The day's most volatile stocks included Moderna, Nvidia and Netflix.
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
11:20am, Monday, 17'th Jan 2022 Zacks Investment Research
Smart Beta ETF report for PBE
BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS
08:00am, Monday, 17'th Jan 2022
MINNEAPOLIS, Jan. 17, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, February 1, 2022, at 8:00 a.m. CST
Should Vanguard SmallCap ETF (VB) Be on Your Investing Radar?
11:20am, Wednesday, 12'th Jan 2022 Zacks Investment Research
Style Box ETF report for VB
Nearly 8% of the S&P 500 has taken a bath this week — 39 stocks fell at least 10%
06:28pm, Saturday, 08'th Jan 2022 MarketWatch
The worst performers in 2022's first week of trading include Humana, Moderna, Netflix and Salesforce.com.
Akoya Biosciences, Bio-Techne team up to develop spatial multiomics workflow
01:10pm, Wednesday, 05'th Jan 2022 Seeking AlphaBIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
07:00am, Monday, 03'rd Jan 2022
MINNEAPOLIS, Jan. 3, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 40th Annual J.P. Morgan H
Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?
06:46pm, Wednesday, 29'th Dec 2021 Zacks Investment Research
Style Box ETF report for VBK
